Waltham, MA and Canoga Park, CA 7/16/12—Thermo Fisher Scientific has agreed to acquire One Lambda for $925 million in cash, subject to post-closing adjustment. One Lambda provides diagnostic tests that are used by transplant centers for tissue typing, primarily to determine the compatibility of donors and recipients pre-transplant and to detect the presence of antibodies […]
Carlsbad, CA 7/25/12—Life Technologies has acquired Pinpoint Genomics, a developer of an early-stage non-small cell lung cancer test for the identification of patients at risk for late-stage disease. “We see an opportunity in lung cancer to change the treatment paradigm with more effective diagnostics,” stated Gregory T. Lucier, chairman and CEO of Life Technologies. “As […]
Carlsbad, CA 7/16/12—Life Technologies has acquired Navigenics, a developer of genetics-based products and services, for an undisclosed amount. Life Technologies stated the acquisition was a first step in its strategy to build out its molecular diagnostics business. “The advent of personalized medicine will require a combination of technologies and informatics focused on delivering relevant information […]
Held July 15–19 in Los Angeles, California, the annual American Association for Clinical Chemistry (AACC) conference hosted tens of thousands of attendees. The conference presentations and exhibits encompassed both traditional clinical chemistry technologies, such as clinical analyzers, as well as molecular diagnostics techniques, including DNA sequencing and PCR. The conference was held at an interesting […]
Higher investments in new product development and increased R&D personnel spending elevated R&D spending in 2011. Total R&D spending in US dollars for 18 major publicly held analytical and life science instrument and lab product companies grew 14.2% to $1.96 billion, compared with 12.1% growth for the same companies in 2010 (see table, page 6). […]
This month, the NSF released preliminary R&D spending numbers for the US federal government for fiscal year 2011 (FY11), ending September 30, 2011. The data suggest the substantial impact that the absence of American Recovery and Reinvestment Act of 2009 (ARRA) funding had on R&D spending in FY11 (see IBO 6/15/12) and general changes in […]
Austin, TX 7/9/12—Luminex has definitely agreed to acquire molecular diagnostics firm GenturaDx for $50 million in cash, subject to working-capital reconciliation and potential contingent consideration. GenturaDx is in late-stage development of an integrated, automated, real-time PCR system that utilizes a single-use cassette. Luminex plans to integrate its MultiCode-RTx chemistry with the instrument and commercialize assays […]
Hilden, Germany and Germantown, MD 6/25/12—QIAGEN has announced the acquisition of next-generation sequencer (NGS) developer Intelligent Biosystems for an undisclosed amount. Further details of the acquisition were unavailable. QIAGEN disclosed the acquisition as part of a broader announcement of its entry into the NGS market. The company plans to launch a complete workflow for NGS, […]
According to recent figures from the NSF, funding from the American Recovery and Reinvestment Act 2009 (ARRA) (see IBO 2/28/09) contributed an additional $17.4 billion in constant fiscal 2005 dollars to federal obligations for R&D and R&D plant (facilities and fixed equipment) funding in fiscal year (FY) 2009 and FY10 combined. This accounted for 7% […]
The number of CROs in the US quadrupled from 2000 to 2011 to reach more than 3,100, according to Tufts Center for the Study of Drug Development (CSDD). Tufts CSDD examined 3,244 US CROs in 15 major geographic areas, which were thought to represent about three-quarters of US CROs. These firms had total 2011 revenues […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
